Systemic lupus erythematosus and primary fibromyalgia can be distinguished by testing for cell-bound complement activation products

OBJECTIVE: We sought to establish the performance of cell-bound complement activation products (CB-CAPs) as a diagnostic tool to distinguish primary fibromyalgia (FM) from systemic lupus erythematosus (SLE). METHODS: A total of 75 SLE and 75 primary FM adult subjects who fulfilled appropriate classi...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Lupus Sci Med
Autors principals: Wallace, Daniel J, Silverman, Stuart L, Conklin, John, Barken, Derren, Dervieux, Thierry
Format: Artigo
Idioma:Inglês
Publicat: BMJ Publishing Group 2016
Matèries:
Biomarker Studies
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4746498/
https://ncbi.nlm.nih.gov/pubmed/26870391
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/lupus-2015-000127
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars